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Abstract. Renal tubular function was studied in 14
patients with Gitelman's syndrome and 14 control
subjects. Apart from the biochemical hallmarks of
Gitelman's syndrome, namely alkalaemia, hyperbi-
carbonataemia, hypokalaemia, hypomagnesaemia
(with increased magnesium over creatinine ratio),
increased urinary chloride over creatinine ratio, and
low urinary calcium over creatinine, the patients were
found to have hyperproteinaemia, hypochloraemia,
high total plasma calcium concentration, reduced
plasma ionized calcium concentration, and high
urinary sodium excretion. A statistically significant
negative linear relationship between plasma magnes-
ium concentration and magnesium excretion corrected
for glomerular filtration was observed in patients. The
fractional calcium clearance and the urinary excretion
of calcium corrected for glomerular filtration was
significantly decreased in patients. In patients the urin-
ary osmolality after overnight water deprivation ranged
from 526 to 1067 mmol/kg. Glucosuria and aminoacid-
uria were similar in patients and controls. The results
of the study demonstrate the renal origin of hypomag-
nesaemia and hypocalciuria in Gitelman's syndrome.
The failure to demonstrate hyperaminoaciduria, hyper-
glucosuria, hyperphosphaturia, hyperuricosuria, and
severely impaired urinary concentrating ability provide
evidence for a defect residing in the distal convoluted
tubule.
Key words: Bartter's syndrome; distal convoluted
tubule; Gitelman's syndrome; hypocalciuria; hypo-
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Introduction
Hypomagnesaemia, hypocalciuria, hypokalaemic
alkalosis, and hyperchloriduria characterize Gitelman's
syndrome, a variant of Bartter's syndrome [1-8].
Correspondence and offprint requests to: Dr M. G. Bianchetti,
Abteilung fur Nephrologie, Universitatskinderklinik, Inselspital,
CH 3010-Bem, Switzerland.
Patients with this tubulopathy, which is inherited in
both dominant and recessive fashions [9], are often
asymptomatic, with the exception of muscular weak-
ness and transient episodes of tetany that are sometimes
accompanied by abdominal pain, vomiting and fever
[1-9].
Since the need for distinguishing between classic
Bartter's syndrome and Gitelman's syndrome has been
challenged until recently [3-9], information on renal
tubular function in this particular disorder is scanty
and based on anecdotal reports [1,2,4-8] and a retro-
spective multicentric inquiry [3]. To address this issue,
simple renal tubular function studies were performed
in 14 patients with Gitelman's syndrome on follow-up
at our centres of Pediatric Nephrology.
Subjects and methods
Fourteen patients with Gitelman's syndrome (7 females and
7 males, aged 10-21 years) entered the study. They had
history of frequent tetanic episodes (« = 3), muscular weak-
ness (« = 7), or both (n = 3). Blood pressure, plasma creatin-
ine, urinalysis, and renal ultrasound were normal. Diagnosis
of Gitelman's syndrome was based on the presence [3] of
normal blood pressure, venous blood pH>7.38, plasma
bicarbonate > 28.0 mmol/1, plasma potassium <3.5mmol/l,
plasma magnesium <0.75 mmol/1 (by colorimetric assay),
molar ratio of urinary calcium over creatinine < 0.100,
urinary chloride over creatinine >8.42 [10], urinary magnes-
ium over creatinine > 0.150 and negative urinary screen for
diuretics. The Z scores for height (from —1.8 to 1.3) and
body weight (from —1.7 to 1.4) were normal.
The 14 patients, who had been without any medication or
electrolyte supplementation for at least 5 weeks prior to
investigation, attended the outpatient clinic after overnight
fasting between 07.00 and 09.00 a.m. They had been
instructed to bring a 3-day food record. The patients received
a 1.21 tap water loading. After voiding the bladder, a 2-h
urine specimen was collected and mid-point blood was taken
with minimal stasis and without movement of the forearm.
Packed-cell volume, blood hydrogen ion concentration,
blood carbon dioxide tension and plasma ionized calcium
concentration were measured in duplicate immediately after
blood collection. The remaining samples were immediately
stored at — 40 °C for later determination of creatinine,
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sodium, potassium, chloride, inorganic phosphorus, uric
acid, total calcium and magnesium concentration in plasma
and urine, and total protein concentration in plasma. The
patients were subsequently asked to provide a portion of a
first morning urine after overnight water deprivation for
determination of osmolality, glucose, protein and amino
acids. The aforementioned protocol was applied in a control
group of 14 healthy volunteers (8 females and 6 males, aged
12 to 20 years).
The study had been approved by the Ethical Committees
of the participant centres and informed consent was obtained.
The intake of sodium, calcium and magnesium was
assessed from the 3-day food record using dietary charts.
Packed-cell volume was assessed by means of a microhaema-
tocrit centrifuge. Blood hydrogen ion concentration, blood
carbon dioxide pressure, and plasma ionized calcium concen-
tration were measured using ion-selective electrodes. The
blood bicarbonate concentration was calculated using the
Henderson-Hasselbalch equation with an acidity exponent
of 6.10 and a carbon dioxide solubility coefficient of 0.0301.
The plasma ionized calcium concentration was not corrected
for blood hydrogen ion concentration. Total protein, creatin-
ine, potassium, chloride, sodium, inorganic phosphorus, uric
acid, total calcium, magnesium, and glucose concentration
were measured with an autoanalyser using either ion-selective
electrodes or colorimetric assays. The urinary concentration
of amino acids was evaluated by column chromathography.
Plasma or urinary electrolytes (Px, Ux) and creatinine (PCr,
UCr) were used to calculate the corresponding fractional
clearance (1) and the urinary excretion corrected for one
liter of glomerular filtration rate (GFR) (2) using the follow-
ing formulae [11]:
ux
PxUCr
U,Pr
(1)
(2)
uCr
The fractional clearance of calcium was calculated both
from total plasma calcium concentration (apparent fractional
calcium clearance) as well as from plasma ionized calcium
concentration (true fractional calcium clearance). Urinary
excretion of electrolytes, amino acids and total protein was
also expressed as ratio over creatinine [11]. The tubular
threshold for inorganic phosphorus (3) was calculated from
plasma phosphorus concentration (Pp) and its fractional
excretion (FEp) using the following formula [12]:
PP-(1-FEP) (3)
The two-tailed Mann-Whitney U test and simple regres-
sions with the rank correlation coefficient (rs) were used for
statistical analysis. Values were expressed either as individual
data or as 25th percentile, median and 75th percentile. A
P<0.05 was regarded as statistical significant [13,14].
alkalaemia, hyperbicarbonataemia, hypokalaemia,
hypomagnesaemia, increased urinary chloride over cre-
atinine ratio, increased urinary magnesium over creati-
nine ratio, and low urinary calcium over creatinine
ratio, the patients were found to have hyperproteinae-
mia, hypochloraemia (and high fractional chloride
excretion), high total plasma calcium concentration,
reduced plasma ionized calcium concentration, and
high urinary sodium excretion (Table 1 and Figure 1).
The body weight tended to be reduced in patients.
In Gitelman's patients the increased urinary magnes-
ium over creatinine ratio was associated with an
increased fractional magnesium clearance and with an
increased magnesium excretion corrected for GFR.
The reduced urinary calcium over creatinine ratio was
associated with low apparent fractional calcium clear-
ance, low true fractional calcium clearance and low
calcium excretion corrected for GFR. The reduced
urinary calcium over creatinine ratio was associated
with low apparent fractional calcium clearance, low
true fractional calcium clearance and low calcium
excretion corrected for GFR (Table 1 and Figure 1).
The urinary osmolality after overnight water
deprivation (Table 2) was slightly but significantly
lower in patients (ranges 526-1067 mmol/kg) than in
controls (ranges 752-1221 mmol/kg). Total protein
excretion, glucosuria, and aminoaciduria were almost
identical in patients and controls (Table 2).
In Gitelman's patients a statistically significant rela-
tionship (Figure 2, panel 1) was observed between
plasma magnesium, taken as independent variable,
and magnesium excretion corrected for GFR, taken
as dependent variable ( j = 77.1-78.5x; rs = 0.79;
P<0.01). In control subjects the two parameters did
not correlate. No significant correlation was found
between circulating magnesium or urinary magnesium
excretion corrected for GFR and urinary calcium or
potassium excretion corrected for GFR in patients and
controls (Figure 2, panels 1-3). In both study groups
no significant correlation was observed between blood
pH or plasma bicarbonate and urinary magnesium,
calcium or potassium excretion corrected for GFR
(Figure 2, panels 5-7, 9-11). Finally, in both groups
no significant correlation was found between urinary
magnesium and urinary potassium excretion corrected
for GFR (Figure 2, panel 8) or between urinary sodium
and urinary calcium excretion corrected for GFR
(Figure 2, panel 12).
Results Discussion
The 14 Gitelman's patients and the 14 control subjects
did not significantly differ with respect to height,
dietary intake of sodium, calcium or magnesium, blood
pressure and heart rate, packed cell volume, plasma
creatinine and sodium, plasma and urinary uric acid,
as well as plasma inorganic phosphorus and tubular
phosphorus threshold (Table 1). Apart from the bio-
chemical hallmarks of Gitelman's syndrome, namely
The present investigation was performed in children
and adolescents with Gitelman's syndrome, the hypo-
calciurica variant of Bartter's syndrome [1-9]. The
study provides information on three phenomena, one
dealing with the mechanisms underlying magnesium
deficiency, one dealing with the mechanisms underlying
hypocalciuria, and one dealing with the site of the
renal tubular dysfunction.
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Table 1. Clinical and biochemical findings in 14 patients with Gitelman's syndrome (aged 14—21 years) and 14 control subjects (aged 14-20
years); data as 25th percentile, median, and 75th percentile
Patients with
Gitelman syndrome
Control
subjects
Body weight (kg)
Height (m)
Supine blood pressure (mmHg)
Supine heart rate (beats/min)
Packed cell volume
Plasma creatinine (umol/1)
Total plasma protein (g/1)
Blood pH
Plasma bicarbonate (mmol/1)
Inorganic phosphorus
plasma concentration (mmol/1)
tubular threshold (mmol/1)
Uric acid
total plasma concentration (umol/1)
fractional clearance (10~2)
excretion (umol/1 GFR)
Potassium
plasma concentration (mmol/1)
urinary potassium over creatinine
fractional clearance (10~2)
excretion (umol/1 GFR)
Chloride
plasma concentration (mmol/1)
urinary chloride over creatinine
fractional clearance (10~2)
excretion (umol/1 GFR)
Sodium
dietary intake (mmol/day)
, urinary sodium over creatinine
plasma concentration (mmol/1)
fractional clearance (10~2)
excretion (umol/1 GFR)
Magnesium
dietary intake (mmol/day)
total plasma concentration (mmol/1)
urinary magnesium over creatinine
fractional clearance (10~2)
excretion (umol/1 GFR)
Calcium
dietary intake (mmol/day)
total plasma concentration (mmol/1)
ionized plasma concentration (mmol/1)
urinary calcium over creatinine
apparent fractional clearance (10~2)
true fractional clearance (10~2)
excretion (umol/1 GFR)
32.8-45.0*-56.1
1.42-1.54-1.66
104-111-115/66-69-73
70-73-77
0.40-0.44-0.47
63-71-81
76.0-78.2*-80.4
7.41-7.43f-7.44
31.0-31.6T-32.2
1.13-1.23-1.42
1.05-1.08-1.17
208-247-329
6.61-8.93-12.3
17.9-22.2-27.2
2.8-2.9f-2.9
4.64-6.02*-10.4
14.7-15.3H-22.6
390-462'-728
94.3-96.0U-101
14.6-17.2t-25.6
1035-1229*-18202
122-190-267
10.8-17.3*-25.4
138-140-141
0.58-0.89*-1.23
803-1236*-1716
8.1-10.1-13.5
0.49-0.55f-0.64
0.384-0.475t-0.582
3.96-5.23H-8.41
23.9-29.1H-44.5
14.5-16.1-18.2
2.45-2.51*-2.56
1.24-1.27*-1.32
0.0130-0.0240t-0.0373
0.0313-0.07161r-0.102
0.0629-0.142U-0.209
0.779-1.81^-2.69
50.8-56.5-63.3
1.63-1.67-1.75
108-110-118/68-70-74
70-73-80
0.40-0.42-0.45
75-77-80
71.8-73.4-75.6
7.32-7.33-7.35
25.7-27.4-29.2
1.19-1.24-1.30
1.08-1.16-1.21
193-216-234
6.35-7.47-9.76
14.7-17.0-18.2
4.2-4.3-4.4
2.33-3.66-5.70
4.90-7.14-10.3
208-303-435
103-104-105
5.3-9.3-14.6
0.35-0.77-1.07
359-805-1124
133-207-268
3.97-7.02-12.8
140-142-143
0.19-0.40-0.78
271-565-1115
9.3-10.2-13.6
0.78-0.81-0.89
0.141-0.165-0.219
1.40-1.66-1.82
10.3-14.0-15.4
11.0-15.5-21.1
2.33-2.39-2.42
1.31-1.33-1.34
0.179-0.242-0.288
0.617-0.788-1.01
1.10-1.42-1.82
14.6-19.3-24.1
t Patients and controls were not compared with respect to this parameter (a statistically significant difference is predictable as the parameter
had to be abnormal for the subjects to be included in the group of patients). */><0.05 and 1J/><0.01 versus control group.
Mechanisms underlying hypomagnesaemia
When magnesium intake is restricted or when its
intestinal absorption is altered, the kidney avidly
retains magnesium [15-17]. In our patients with hypo-
magnesaemia the urinary magnesium excretion was
higher than in healthy controls. This fact, together
with the observed correlation between plasma magnes-
ium and urinary magnesium excretion corrected for
GFR, demonstrates the renal origin of magnesium
wasting. Blood pH and plasma bicarbonate may modu-
late the urinary magnesium excretion [15-17], but in
this study no correlation was found between blood
hydrogen ion level or plasma bicarbonate and urinary
magnesium excretion corrected for GFR. Dietary mag-
nesium was similar in Gitelman's patients and in
controls. On the contrary, the urinary magnesium
excretion was higher in Gitelman's patients than in
controls. Taken together these data point to high
intestinal magnesium absorption as a compensation
for renal loss of magnesium in Gitelman's patients.
Mechanisms underlying hyocalciuria
High total plasma calcium concentration but low ion-
ized plasma calcium concentration were observed in
our patients with Gitelman's syndrome. Calcium in
body fluids exists in three forms, namely the form
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Fig. 1. Total plasma calcium, plasma ionized calcium, molar urinary calcium over creatinine, apparent fractional calcium clearance, true
fractional calcium clearance, and calcium excretion corrected for GFR in 14 patients with Gitelman's syndrome (black symbols) and 14
control subjects (open symbols).
Table 2. Urinary osmolality, proteinuria, glucosuria, and aminoaciduria in 14 patients with Gitelman's syndrome aged 14-21 years, and 14
control subjects aged 14-20 years; data as 25th percentile, median, and 75th percentile ,
Patients with
Gitelman syndrome
Control
subjects
Urinary osmolality (mmol/kg)
Protein over creatinine (mg/mmol)
Glucose (mmol/l)
Alanine over creatinine (10~3)
Arginine over creatinine (10~3)
1/2 Cystine over creatinine (10~3)
Glutamic acid over creatinine (10~3)
Glycine over creatinine (10~3)
Histidine over creatinine (10~3)
Isoleucine over creatinine (10~3)
Leucine over creatinine (10~3)
Lysine over creatinine (10~3)
Methionine over creatinine (10~3)
Ornithine over creatinine (10~3)
Phenylalanine over creatinine (10~3)
Proline over creatinine (10~3)
Serine over creatinine (10~3)
Taurine over creatinine (10~3)
Threonine over creatinine (10~3)
Tyrosine over creatinine (10~3)
Valine over creatinine (10~3)
626-6991-749
5.6-7.8-14
0.28-0.79-1.2
25-42-55
2-4-5
1-10-15
11-18-20
87-158-222
38-84-125
1-2-5
1-4-5
29-35-46
1-2-3
1-4-6
7-9-12
l^*-7
23-38-55
34-44-67
10-21-36
15-17-21
2-6-7
931-977-1104
5.2-8.3-12
0.39-0.64-0.97
29-50-59
2-4-5
8-11-23
8-15-20
57-144-214
33-58-108
1-4-5
1-2-7
34-43-48
1-2-3
4-5-6
5-7-10
2-5-7
23-32-55
30-44-70
11-19-35
10-15-21
1-4-8
%P<0.05 versus control group.
The aminoaciduria is given as molar ratio over creatinine.
bound to proteins, the form complexed with low-
molecular-weight anions such as bicarbonate, and the
free or ionized form, the only form biologically active
[18]. Plasma ionized calcium concentration appears
therefore dependent on several factors. The amount of
circulating calcium bound to proteins or complexed to
bicarbonate increases with a decline in hydrogen ion
concentration and with an increase in plasma bicarbon-
ate or proteins: these facts account for the discrepancy
between high total and low ionized calcium concentra-
tion in our group of Gitelman's patients presenting
with hyperbicarbonataemia, alkalaemia, and hyper-
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Fig. 2. Relationship between plasma magnesium and urinary magnesium excretion corrected for GFR (panel I), between plasma magnesium
and urinary calcium excretion corrected for GFR (panel 2), between plasma magnesium and urinary potassium excretion corrected for
GFR (panel 3), between urinary magnesium excretion corrected for GFR and urinary calcium excretion corrected for GFR (panel 4),
between blood pH and urinary magnesium excretion corrected for GFR (panel 5), between blood pH and urinary calcium excretion
corrected for GFR (panel 6), between blood pH and urinary potassium excretion corrected for GFR (panel 7), between urinary magnesium
excretion corrected for GFR and urinary potassium excretion corrected for GFR (panel 8), between plasma bicarbonate and urinary
magnesium excretion corrected for GFR (panel 9), between plasma bicarbonate and urinary calcium excretion corrected for GFR
(panel 10), between plasma bicarbonate and urinary potassium excretion corrected for GFR (panel 11), between urinary sodium excretion
corrected for GFR and urinary calcium excretion corrected for GFR (panel 12) in 14 patients with Gitelman's syndrome (black symbols)
and 14 control subjects (open symbols). In patients a significant (/><0.05) relationship was observed between circulating and urinary
magnesium (y = 77.1 -78.5JC; r, = 0.79; P<0.0\; panel 1).
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proteinaemia. The tendency towards hypocalcaemia
observed in our patients with Gitelman's syndrome is
probably the consequence of a blunted secretion of
parathyroid hormone induced by hypomagnesaemia
[15-17,19].
Severe hypocalciuria, expressed either as calcium
over creatinine ratio, as apparent or true fractional
calcium clearance, or as calcium excretion corrected
for GFR, is the most striking feature in Gitelman's
syndrome. The results of dietary records indicate that
in our patients hypocalciuria does not result from low
dietary calcium intake. Dietary sodium intake modu-
lates the urinary calcium excretion but in this study
we found a similar dietary salt intake in patients and
controls without any correlation between excretion of
calcium and sodium. Finally, in Gitelman's syndrome
hypocalciuria may be related only in part to mild
concomitant hypocalcaemia, since both the true frac-
tional calcium clearance and the calcium excretion
corrected for GFR were low, indicating avid tubular
reabsorption. Hypomagnesaemia promotes tubular
calcium reabsorption [15-17]. For that reason it has
been suggested that hypocalciuria in Gitelman's syn-
drome may be secondary to hypomagnesaemia, but in
our patients no correlation was found between urinary
calcium excretion corrected for GFR and urinary
magnesium excretion corrected for GFR or plasma
magnesium. Data from the literature indicate that in
Gitelman's syndrome urinary calcium excretion
remains low even after correction of magnesium defi-
ciency [4]. This fact and our observations suggest that
in Gitelman's syndrome hypomagnesaemia is not the
cause of hypocalciuria. Whatever the underlying mech-
anisms, increased tubular reabsorption of calcium
appears a diagnostic sine qua non for this variant of
Bartter's syndrome [1-9].
Site of the tubular defect in Gitelman's syndrome
The present study provides information on the prox-
imal tubular function and on the ability to concentrate
urine in Gitelman's syndrome. A proximal tubular
defect has been sometimes reported in patients with
Bartter's syndrome [20]. In our Gitelman's patients
the failure to demonstrate excessive urinary excretion
of amino acids, glucose, phosphorus, and uric acid
suggests a normal proximal tubular function [21-23].
In Gitelman's patients the urinary osmolality after
overnight fasting was always higher than 526 mmol/kg.
This fact provides evidence against a disturbance
residing in the loop or in the collecting tubule [24,25].
The slightly reduced urinary osmolality observed in
Gitelman's patients as compared with controls is prob-
ably related to the concomitant potassium depletion
[24,25].
The laboratory features of Gitelman's syndrome
resemble those induced by thiazides, which bind to
and inhibit the luminal sodium-chloride cotransporter
in the distal convoluted tubule [3-5,7]. A blunted
response to thiazides has been reported in adult
patients with this tubulopathy [4]. Taken together, the
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results of the present investigation and the aforemen-
tioned observations indicate that Gitelman's syndrome
appears best explained by a defective sodium-chloride
carrier protein along the distal convoluted tubule.
However, the primary tubular abnormality and the
events underlying the characteristic biochemical dis-
turbances of Gitelman's syndrome are still incom-
pletely understood. Molecular biology studies are
required to definitely answer this question.
Conclusion
The present study on Gitelman's syndrome demon-
strates the renal origin of magnesium deficiency and
hypocalciuria and provide some evidence for a defect
residing in the distal convoluted tubule.
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